M&G Investment Management LTD Macrogenics Inc Transaction History

M&G Investment Management LTD

  • $28.2 Trillion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 18, 2022
SELL
$15.91 - $21.88 $251,982 - $346,535
-15,838 Closed
0 $0
Q3 2021

Nov 09, 2021
SELL
$19.74 - $28.7 $217,238 - $315,843
-11,005 Reduced 41.0%
15,838 $331,000
Q2 2021

Aug 16, 2021
BUY
$20.49 - $35.63 $550,013 - $956,416
26,843 New
26,843 $725,000

Others Institutions Holding MGNX

# of Institutions
134
Shares Held
55.5M
Call Options Held
215K
Put Options Held
238K
View Full List

About MACROGENICS INC

MGNX Quotes by TradingView
  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $199M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track M&G Investment Management LTD Portfolio

Follow M&G Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on M&G Investment Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email